November 16, 2026

MARPE with Custom 3D‑appliance has high success, low complications

Adult maxillary expansion is an important area of orthodontics. For years, we believed surgically assisted expansion was necessary for most adults with a significant transverse maxillary discrepancy. However, the development of miniscrew-assisted rapid palatal expansion (MARPE) has challenged this assumption.

As with many orthodontic innovations, enthusiasm for this treatment has grown rapidly. We now see increasingly sophisticated appliances and digital planning. In this new paper, Audrey Yoon and her team report a 98% success rate for customised 3D-printed MARPE in adults.

A team from California did this study. The AJO-DO Clinical Companion published the paper.

Regular readers of my blog will know that I do not usually review studies published in clinical report journals. However, I thought this study was relevant and more than a simple clinical report.

What did they ask?

“This study assessed the success rates and complications associated with a new customised 3D-printed mini-screw-assisted rapid palatal expansion appliance”. 

What did they do?

The team conducted a retrospective analysis of 100 consecutive patients older than 18 years (mean age 32.9 ± 11.7). The sample comprised 58 males and 42 females who underwent customised 3D-printed miniscrew-assisted rapid palatal expansion (MARPE). Seventy-nine were treated at a private practice, and 21 at a graduate orthodontic clinic. 

One orthodontist designed all the MARPEs. All appliances were hybrid tooth-bone-borne MARPEs with customised 3D-printed bands. Some appliances had additional features, such as lingual extensions, intrusion arms, and face mask hooks. 

The operator placed mini screws during virtual planning using intraoral scans and CBCT images. The primary locations were along the mid-palatal suture, with secondary placements on the palatal shelves. 

The number of mini screws varied by age and gender. They used 4 to 6 screws for patients under 20, 6 screws for most ages, and 8+ screws for males over 40. Expansion was performed at a rate of 1 turn per day for the first 2 weeks, or until a visual diastema confirmed sutural opening. 

Importantly, they defined successful treatment as achieving a visual midline diastema.

They assessed inflammation around the appliance using clinical photographs and intraoral scans, and they also recorded treatment-related pain. Finally, other outcomes included swelling, gagging, sinus infections, haematoma, and screw failure.

They calculated simple descriptive statistics. 

What did they find? 

Results showed that 98% of patients achieved a visible diastema. They suggested this was due to successful opening of the midpalatal suture. This was the primary outcome.

They further analysed the data and reported that 96.6% of male and 100% of female patients had diastema opening.

When they looked at complications, the most frequent was inflammation, occurring in 32% of cases. Furthermore, 29% of patients reported pain during expansion, and a very small number had broken screws. 

Their overall conclusion was 

“Custom 3D-printed MARPE enhances success rate while reducing pain and complications.” 

Nevertheless, they also stated that prospective comparative studies should be conducted to evaluate outcomes relative to conventional MAPI or surgically assisted expansion. 

What did I think? 

I thought this was an interesting clinical study. The investigators have described their technique carefully, included consecutive patients, and reported complications.

I think it is remarkable that this study reported such a high success rate. I’m not aware of any orthodontic treatment with such a high success rate. As a result, I reviewed this paper very critically.

One factor we need to consider is whether a midline diastema is an appropriate outcome measure. This seems a reasonable clinical indicator that the midpalatal suture may have separated. However, I don’t think this is the same as demonstrating successful skeletal maxillary expansion. I know this was a criticism of a previous study I posted on a few weeks ago. Nevertheless, this suggests that expansion likely occurred, although it does not quantify this important measure. 

We also need to consider the retrospective nature of this study. The authors provide very limited information on the inclusion criteria and the number of patients screened to derive this final sample. The authors note that these patients received consecutive treatments. However, they did not provide any information on the time period during which the treatment was carried out. 

A highly experienced operator carried out these appliances and the treatment; we cannot assume findings generalise to the average orthodontist. This is particularly relevant when we look at a prospective study that reported an overall success rate of 66%. This was substantially lower than the present study. This difference could reflect Dr Yoon’s considerable experience with this form of treatment compared with other orthodontists.

Finally, a cursory read of this paper may suggest that the customised appliances improve success and reduce complications, as the authors conclude. At first sight, this appears to support the new approach as being more effective. Nevertheless, a fundamental problem remains: this study did not include a conventional MARPE comparison group; the investigators compared their results with those of a previously published study. This low-quality historical comparison is vulnerable to several sources of bias. This is a classic example of the difference between observing a good result and demonstrating that a treatment is better. 

I also cannot help but mention that this study tells us nothing about the effect of expansion on the airway. Before we all get excited!

Final thoughts 

Because of these limitations, I feel that this is a useful descriptive clinical study, but it provides very limited evidence on the comparative effectiveness of different treatment approaches. This study is best viewed as evidence that a technique can work well in a particular clinical setting, rather than as evidence that it should be a preferred treatment. Again, the authors have acknowledged this by stating that further prospective comparative studies are required. 

It would be great if this team can carry out these studies. 

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *